Gynecologic Oncology, University Hospitals Leuven, Herestraat, 49, 3000 Leuven, Belgium; Division of Oncology, KULeuven, Herestraat, 49, 3000 Leuven, Belgium.
Department of Obstetrics and Gynecology, 2nd Medical Faculty, Charles University, Ovocný trh, 5, 11636 Prague, Czech Republic.
Eur J Cancer. 2014 May;50(8):1462-71. doi: 10.1016/j.ejca.2014.02.018. Epub 2014 Mar 14.
The concurrence of intracranial tumours with pregnancy is rare. The purpose of this study was to describe all reported patients registered in the international Cancer in Pregnancy registration study (CIP study; http://www.cancerinpregnancy.org), and to review the literature in order to obtain better insight into outcome and possibilities of treatment in pregnancy.
We collected all intracranial tumours (primary brain tumour, cerebral metastasis, or meningioma) diagnosed during pregnancy, registered prospectively and retrospectively by international collaboration since 1973. Patients diagnosed postpartum were excluded. We summarised the demographic features, treatment decisions, obstetrical and neonatal outcomes.
The mean age of the 27 eligible patients was 31years (range 23-41years), of which 13 and 12 patients were diagnosed in the second and third trimesters, respectively. Eight patients (30%) underwent brain surgery, seven patients (26%) had radiotherapy and in three patients (11%) chemotherapy was administered during gestation. Two patients died during pregnancy and four pregnancies were terminated. In 16 (59%) patients elective caesarean section was performed of which 14 (52%) were still preterm (range 30-36weeks, mean 33weeks). Five patients had a vaginal delivery (range 36-40weeks). Of the 21 ongoing pregnancies all children were born alive without visible congenital malformations and the available long-term follow-up data (range 2-25years) of six children were reassuring.
Adherence to standard protocol for the treatment of brain tumours during pregnancy appears to allow a term delivery and a higher probability of a vaginal delivery.
颅内肿瘤合并妊娠较为罕见。本研究旨在描述国际妊娠癌症注册研究(CIP 研究;http://www.cancerinpregnancy.org)中所有报告的患者,并对文献进行回顾,以便更好地了解妊娠期间的治疗效果和可能性。
我们收集了自 1973 年以来通过国际合作前瞻性和回顾性登记的所有妊娠期间诊断的颅内肿瘤(原发性脑肿瘤、脑转移瘤或脑膜瘤)。排除产后诊断的患者。我们总结了患者的人口统计学特征、治疗决策、产科和新生儿结局。
27 名符合条件的患者的平均年龄为 31 岁(范围 23-41 岁),其中 13 名和 12 名患者分别在妊娠第二和第三个三个月被诊断。8 名患者(30%)接受了脑部手术,7 名患者(26%)在妊娠期间接受了放疗,3 名患者(11%)接受了化疗。2 名患者在妊娠期间死亡,4 例妊娠终止。在 16 名(59%)患者中进行了选择性剖宫产,其中 14 名(52%)仍为早产(范围 30-36 周,平均 33 周)。5 名患者经阴道分娩(范围 36-40 周)。21 例持续妊娠中,所有儿童均顺产,无明显先天畸形,6 例儿童的可用长期随访数据(范围 2-25 年)令人安心。
在妊娠期间遵循脑肿瘤治疗标准方案似乎可以实现足月分娩和阴道分娩的更高可能性。